Jin LI

2 clinical trials · Sponsor

Record	Firm	Date
A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer (NCT07466901)	Jin LI	2026-04-01
Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment (NCT06081595)	Jin Li	2023-10-30

Every clearance here is in the API, with alerts when new ones post.